March 24, 2026 – ZOLL® will spotlight the most recent analysis in sudden cardiac demise, case experiences for decreasing coronary heart failure readmissions, and two Innovation Stage displays on the American School of Cardiology Annual Scientific Session & Expo (ACC.26), March 28-30, 2026. ZOLL will sponsor a sequence of academic packages to have interaction and join physicians to new proof and evolving practices in cardiac care:

Two ZOLL-sponsored displays might be held through the ACC Innovation Stage:

• A pleasant debate on approaches to HFrEF affected person administration with GDMT, together with the LifeVest® wearable cardioverter-defibrillator (WCD) as a therapy choice.
• A case examine highlighting the discount of HF readmission to single digits via the implementation of ZOLL’s Coronary heart Failure Administration System (HFMS).

ZOLL sponsors the ACC Girls in Cardiology Combine N’ Mingle, in addition to occasions for cardiology college students and residents.

ZOLL may even spotlight improvements in sales space 2437, together with the LifeVest WCD, ZOLL HFMS, TherOx® SuperSaturated Oxygen Remedy and WatchPAT® sleep apnea options.

Proceed studying